Literature DB >> 30176443

Long-term organoid culture reveals enrichment of organoid-forming epithelial cells in the fimbrial portion of mouse fallopian tube.

Ying Xie1, Eun-Sil Park2, Dongxi Xiang2, Zhe Li3.   

Abstract

A recent paradigm shift in ovarian cancer research is the finding that many ovarian cancers may originate from fallopian tube epithelial (FTE) cells. As tissue stem and progenitor cells often serve as cells of origin of cancer, a better understanding of FTE stem/progenitor cells and how they become transformed is essential for early detection and prevention of ovarian cancer. To facilitate study of FTE stem/progenitor cells in model systems, we established an organoid culture system for mouse FTE cells. We find that EPCAM+ mouse FTE cells can be stably cultured long-term under a minimal condition of activated EGF signaling and suppressed TGFbeta signaling. We show that both Notch and Wnt signaling are required for growth of FTE cells in organoids, and further activation of Wnt signaling supports their maturation toward the ciliated cell lineage. Lastly, by analyzing the frequency of organoid-forming cells in different portions of the fallopian tube (FT), we find that the distal portion of the FT, which includes the fimbria, is enriched with organoid-forming FTE stem cells.
Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cellular origin of ovarian cancer; Fallopian tube epithelial cell; Fimbria; Organoid culture; Oviduct; Tissue stem cell

Mesh:

Substances:

Year:  2018        PMID: 30176443     DOI: 10.1016/j.scr.2018.08.021

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  18 in total

1.  Reprogramming Mouse Oviduct Epithelial Cells Using In Vivo Electroporation and CRISPR/Cas9-Mediated Genetic Manipulation.

Authors:  Matthew J Ford; Yojiro Yamanaka
Journal:  Methods Mol Biol       Date:  2022

2.  Equine Oviductal Organoid Generation and Cryopreservation.

Authors:  Riley E Thompson; Mindy A Meyers; D N Rao Veeramachaneni; Budhan S Pukazhenthi; Fiona K Hollinshead
Journal:  Methods Protoc       Date:  2022-06-15

Review 3.  A tale of two tracts: history, current advances, and future directions of research on sexual differentiation of reproductive tracts†.

Authors:  Fei Zhao; Humphrey Hung-Chang Yao
Journal:  Biol Reprod       Date:  2019-09-01       Impact factor: 4.285

Review 4.  Organoids in Tissue Transplantation.

Authors:  Derya Sağraç; Hatice Burcu Şişli; Selinay Şenkal; Taha Bartu Hayal; Fikrettin Şahin; Ayşegül Doğan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Organ-on-a-chip technology for the study of the female reproductive system.

Authors:  Rachel E Young; Dan Dongeun Huh
Journal:  Adv Drug Deliv Rev       Date:  2021-04-06       Impact factor: 17.873

6.  WNT and inflammatory signaling distinguish human Fallopian tube epithelial cell populations.

Authors:  Ian M Rose; Mallikarjun Bidarimath; Alex Webster; Andrew K Godwin; Andrea Flesken-Nikitin; Alexander Yu Nikitin
Journal:  Sci Rep       Date:  2020-06-17       Impact factor: 4.379

Review 7.  Organoid technology in female reproductive biomedicine.

Authors:  Heidar Heidari-Khoei; Fereshteh Esfandiari; Mohammad Amin Hajari; Zeynab Ghorbaninejad; Abbas Piryaei; Hossein Baharvand
Journal:  Reprod Biol Endocrinol       Date:  2020-06-18       Impact factor: 5.211

Review 8.  Organoids of epithelial ovarian cancer as an emerging preclinical in vitro tool: a review.

Authors:  Sander Dumont; Ziga Jan; Ruben Heremans; Toon Van Gorp; Ignace Vergote; Dirk Timmerman
Journal:  J Ovarian Res       Date:  2019-11-08       Impact factor: 4.234

9.  Human fallopian tube epithelial cells exhibit stemness features, self-renewal capacity, and Wnt-related organoid formation.

Authors:  Yu-Hsun Chang; Tang-Yuan Chu; Dah-Ching Ding
Journal:  J Biomed Sci       Date:  2020-02-08       Impact factor: 8.410

10.  Development of a 3D functional assay and identification of biomarkers, predictive for response of high-grade serous ovarian cancer (HGSOC) patients to poly-ADP ribose polymerase inhibitors (PARPis): targeted therapy.

Authors:  Razan Sheta; Magdalena Bachvarova; Marie Plante; Marie-Claude Renaud; Alexandra Sebastianelli; Jean Gregoire; Jamilet Miranda Navarro; Ricardo Bringas Perez; Jean-Yves Masson; Dimcho Bachvarov
Journal:  J Transl Med       Date:  2020-11-19       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.